DeepMed Research

GH RESEARCH IRELAND LIMITED

🇮🇪Ireland

Country: 🇮🇪Ireland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

Phase 1

Recruiting

Conditions: Healthy Volunteers

Interventions: Drug: 5 Methoxy N,N Dimethyltryptamine

First Posted Date: 2024-07-22

Last Posted Date: 2024-08-07

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 52

Registration Number: NCT06511947

Locations: 🇬🇧
GH Research Clinical Trial Site, London, United Kingdom

Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

Phase 2

Terminated

Conditions: Bipolar II Disorder

Interventions: Drug: GH001

First Posted Date: 2023-05-03

Last Posted Date: 2025-02-18

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 6

Registration Number: NCT05839509

Locations: 🇬🇧
Investigational Site, London, United Kingdom
🇬🇧
Investigation Site, Oxford, United Kingdom

Phase 2 Clinical Trial of GH001 in Postpartum Depression

Phase 2

Terminated

Conditions: Postnatal Depression
Postpartum Depression

Interventions: Drug: GH001

First Posted Date: 2023-04-07

Last Posted Date: 2025-02-18

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 10

Registration Number: NCT05804708

Locations: 🇳🇱
Amsterdam UMC, Amsterdam, Netherlands
🇬🇧
Clerkenwell Health, London, United Kingdom
🇬🇧
St. Pancras Clinical Research, London, United Kingdom

and more 1 locations

A Trial of GH001 in Patients with Treatment-resistant Depression

Phase 2

Active, not recruiting

Conditions: Treatment-resistant Depression

Interventions: Drug: GH001
Drug: Placebo

First Posted Date: 2023-04-06

Last Posted Date: 2024-11-29

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 80

Registration Number: NCT05800860

Locations: 🇮🇪
Investigational site, Dublin, Ireland
🇪🇸
Investigational Site, Salamanca, Spain

Safety and Pharmacokinetics of GH002 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: 5 Methoxy N,N Dimethyltryptamine
Drug: Placebo

First Posted Date: 2023-03-03

Last Posted Date: 2024-01-25

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 64

Registration Number: NCT05753956

Locations: 🇳🇱
GH Research Clinical Trial Site, Groningen, Netherlands

Pharmacokinetics of GH001 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: 5 Methoxy N,N Dimethyltryptamine
Drug: Placebo

First Posted Date: 2021-12-20

Last Posted Date: 2021-12-20

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 46

Registration Number: NCT05163691

Locations: 🇳🇱
GH Research Clinical Trial Site, Groningen, Netherlands

Clinical Study of GH001 in Depression

Phase 1

Completed

Conditions: Major Depressive Disorder
Treatment Resistant Depression
Depression

Interventions: Drug: 5 Methoxy N,N Dimethyltryptamine

First Posted Date: 2021-01-07

Last Posted Date: 2023-08-15

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 16

Registration Number: NCT04698603

Locations: 🇳🇱
Clinical Trial Site, Maastricht, Netherlands

Safety of GH001 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: 5 Methoxy N,N Dimethyltryptamine

First Posted Date: 2020-11-23

Last Posted Date: 2023-08-15

Lead Sponsor: GH Research Ireland Limited

Target Recruit Count: 22

Registration Number: NCT04640831

Locations: 🇳🇱
Clinical Trial Site, Maastricht, Netherlands

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy